All currently used anthrax vaccines show considerable local and general reactogenicity (erythema, induration, soreness, fever) and serious adverse reactions occur in about 1% of recipients.
Studies have shown a weak correlation between cooling down and less muscle delayed-onset muscle soreness, however the majority of recent studies discount this relationship.